Viz.ai Studies Show AI Speeds Heart Disease Detection

Viz.ai announced that three new studies featuring its Cardio Suite technology have been accepted for a major medical conference ^[1]. These findings will be presented at the American College of Cardiology's Annual Scientific Session, known as ACC.26 ^[2]. The research demonstrates that AI-enabled ECG screening can effectively identify patients with undiagnosed heart disease ^[3]. One primary focus of the research is the earlier detection of hypertrophic cardiomyopathy ^[1]. The studies also highlight how the technology helps medical teams re-engage patients who were previously lost to follow-up care ^[2]. By automating the screening process, the Cardio Suite speeds up the time between initial detection and necessary treatment ^[3].